Valvular & structural heart disease

Feasibility of redo-TAVI in self-expanding Evolut valves: a computed tomography (CT) analysis from the Evolut Low Risk Trial substudy

EuroInterventionPublished CT substudy of the Evolut Low Risk randomised trial

Authors' conclusion

The feasibility of redo-TAVI after Evolut failure is multifactorial and relates to the native annular anatomy, as well as the implantation depth of the index and second bioprostheses. Placement of an S3 at a lower Evolut position may reduce the risk of coronary flow compromise while preserving coronary access.

Study context

Population
Patients with self-expanding Evolut TAVI (post-TAVI CT scans, Evolut Low Risk CT substudy)
Participants
204 post-TAVI CT scans
Comparison
Simulated redo-TAVI positions
Primary endpoint
Risk of coronary flow compromise after simulated redo-TAVI (neoskirt height and post-TAVI aortic root dimensions)
Methodological detailssimulation of redo-TAVI positions
  • Simulation of redo-TAVI positions

Primary result

As reported in the abstract

Risk of coronary flow compromise

Further findings

Coronary accessibility

Highest likelihood of preserving coronary accessibility with S3 outflow at Evolut node 4

Factors associated with coronary flow compromise (univariable)

Higher risk with female sex, higher BMI, smaller annulus diameter, lower sinus of Valsalva height and width, shorter coronary height, smaller sinotubular junction diameter, shallower Evolut implant depth

Original publication

Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy. EuroIntervention. Published 17 July 2023. doi:10.4244/eij-d-22-01125

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.